Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BWAY · against 588 other Healthcare companies listed in US-listed
Ranked #225 of 589 · scores higher than 61% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 40–49, including BWAY · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | BWAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.1% | -4.3% | 72% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.2% | -0.8% | 58% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 1.3% | -2.3% | 64% | 20% | |
| Book yieldHigher is better · 587 reported | 17.7% | 25.9% | 38% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 219 | 5.8B USD | 42 | 38 | |
| 225 | 7.7B USD | 41 | 37 | |
| 225 | 13.2B USD | 41 | 30 | |
| 225 | 10.8B USD | 41 | 41 | |
| 225 | 449M USD | 41 | 72 | |
| 225 | 12.6B USD | 41 | 65 | |
| 225 | 1.6B USD | 41 | 29 | |
| 225 | 2.1B USD | 41 | 61 | |
| 232 | 1.2B USD | 40 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score